Oura's $15.6 Billion IPO Targets Nasdaq Debut with Subscription Growth
Oura Inc., a wearable health technology company, is preparing for an initial public offering (IPO) on the Nasdaq under the ticker symbol OURA during the week of September 28, 2026. The firm plans to offer 50 million shares at $40–$44 each, aiming for a valuation up to $15.6 billion fully diluted. Subscription revenue grew by 121% year-over-year in the first nine months of 2026, reaching $240.5 million and contributing to an improved gross margin of 55%. The company reported net income of $60.8 million during this period. Oura is transitioning from a consumer wellness device into a biometric data platform for metabolic healthcare, supported by partnerships with pharmaceutical companies like Eli Lilly, which has expressed interest in purchasing up to $100 million worth of shares and collaborating on health tracking initiatives. The company's membership model—$5.99 per month—has driven recurring revenue growth and improved customer retention metrics. The IPO reflects investor confidence despite the challenges hardware startups often face with cyclical consumer demand.
Tickers: $LLY